Kamada Ltd. (TLV:KMDA)
2,506.00
+6.00 (0.24%)
Jan 14, 2026, 5:24 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.44 billion as of January 14, 2026. Its market cap has increased by 13.75% in one year.
Market Cap
1.44B
Enterprise Value
1.24B
Revenue
578.74M
Ranking
n/a
PE Ratio
21.60
Stock Price
2,506.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.44B, an increase of 1,609.57%. That is a compound annual growth rate of 14.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 1.44B | 10.62% |
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.23B |
| Danel (Adir Yeoshua) | 2.84B |
| BrainsWay | 1.51B |
| SofWave Medical | 1.26B |
| Bait Bakfar | 1.09B |
| Ilex Medical | 770.41M |
| Novolog (Pharm-Up 1966) | 664.14M |
| Bonus BioGroup | 623.67M |